Polyphenols selectively reverse early-life stress-induced behavioural, neurochemical and microbiota changes in the rat.
Animals
Female
Male
Pregnancy
Rats
Age Factors
Antidepressive Agents
/ pharmacology
Antioxidants
/ pharmacology
Behavior, Animal
/ drug effects
Brain
/ drug effects
Brain-Derived Neurotrophic Factor
/ drug effects
Disease Models, Animal
Flavonoids
/ pharmacology
Gastrointestinal Microbiome
/ drug effects
Polyphenols
/ pharmacology
Propiophenones
/ pharmacology
Quercetin
/ pharmacology
Rats, Sprague-Dawley
Stress, Psychological
/ diet therapy
Early-life stress
Microbiota-Gut-Brain axis
Polyphenols
Journal
Psychoneuroendocrinology
ISSN: 1873-3360
Titre abrégé: Psychoneuroendocrinology
Pays: England
ID NLM: 7612148
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
13
12
2019
revised:
07
02
2020
accepted:
25
03
2020
pubmed:
26
4
2020
medline:
23
4
2021
entrez:
26
4
2020
Statut:
ppublish
Résumé
There is a growing emphasis on the role of the microbiota-gut-brain axis as modulator of host behaviour and as therapeutic target for neuropsychiatric disorders. In addition, accumulating evidence suggests that early-life stress can exert long-lasting changes on the brain and microbiota, and this early adversity is associated with increased risk for developing depression in later life. The maternal separation (MS) model in rats is a robust paradigm to study the effects of early-life stress on the microbiota-gut-brain axis. Recently, we have shown that polyphenols, naturally occurring compounds associated with several health benefits, have anti-stress effects in in vitro models. In this study, we assess the therapeutic potential of a variety of both flavonoid and non-flavonoid polyphenols in reversing the impact of MS on behaviour and the microbiota-gut-brain axis. Rats underwent a dietary intervention with the naturally-derived polyphenols xanthohumol and quercetin, as well as with a phlorotannin extract for 8 weeks. Treatment with polyphenols prevented the depressive- and anxiety-like behaviours induced by MS, where xanthohumol effects were correlated with rescue of BDNF plasma levels. In addition, MS resulted in altered brain levels of 5-hydroxyindoleacetic acid (5-HIAA) and dopamine, accompanied by abnormal elevation of plasma corticosterone. Although polyphenols did not reverse neurotransmitter imbalance, xanthohumol normalised corticosterone levels in MS rats. Finally, we explored the impact of MS and polyphenolic diets on the gut microbiota. We observed profound changes in microbial composition and diversity produced by MS condition and by xanthohumol treatment. Moreover, functional prediction analysis revealed that MS results in altered enrichment of pathways associated with microbiota-brain interactions that are significantly reversed by xanthohumol treatment. These results suggest that naturally-derived polyphenols exert antidepressant-like effects in MS rats, which mechanisms could be potentially mediated by HPA regulation, BDNF levels rescue and modulation of the microbiota-gut-brain axis.
Identifiants
pubmed: 32334345
pii: S0306-4530(20)30092-5
doi: 10.1016/j.psyneuen.2020.104673
pii:
doi:
Substances chimiques
Antidepressive Agents
0
Antioxidants
0
Bdnf protein, rat
0
Brain-Derived Neurotrophic Factor
0
Flavonoids
0
Polyphenols
0
Propiophenones
0
Quercetin
9IKM0I5T1E
xanthohumol
T4467YT1NT
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
104673Informations de copyright
Copyright © 2020 Elsevier Ltd. All rights reserved.